Odyssey Health (ODYY) Net Cash Flow Growth (3y) (2017 - 2026)
Odyssey Health (ODYY) Net Cash Flow Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 128.80 Bn | 125.92 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 48.37 Bn | 44.70 Bn | 1.29 Bn | -87.88% |
| 6 | Dexcom | 28.41 Bn | 27.30 Bn | 750.30 Mn | 129.29% |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.04 Bn | 1.98 Bn | -65.12% |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | -48.90% |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | -109.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -109.67% |
| Jan 31, 2026 | 248.06% |
| Oct 31, 2025 | 31.91% |
| Jul 31, 2025 | -58.31% |
| Apr 30, 2025 | -26.61% |
| Jan 31, 2025 | 48.40% |
| Oct 31, 2024 | 37.55% |
| Jul 31, 2024 | 66.90% |
| Apr 30, 2024 | -27.57% |
| Jan 31, 2024 | 48.30% |
| Oct 31, 2023 | -11.18% |
| Jul 31, 2023 | -0.63% |
| Apr 30, 2023 | -51.06% |
| Jan 31, 2023 | 47.14% |
| Oct 31, 2022 | 30.19% |
| Jul 31, 2022 | 9.58% |
| Apr 30, 2022 | 666.53% |
| Jan 31, 2022 | -866.82% |
| Oct 31, 2021 | -420.40% |
| Jul 31, 2021 | -573.10% |